KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Gross Profit (2016 - 2025)

Medpace Holdings' Gross Profit history spans 11 years, with the latest figure at $205.3 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 15.14% year-over-year to $205.3 million; the TTM value through Dec 2025 reached $760.6 million, up 15.89%, while the annual FY2025 figure was $760.6 million, 15.89% up from the prior year.
  • Gross Profit reached $205.3 million in Q4 2025 per MEDP's latest filing, up from $196.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $205.3 million in Q4 2025 to a low of $74.7 million in Q2 2021.
  • Average Gross Profit over 5 years is $135.1 million, with a median of $131.7 million recorded in 2023.
  • Peak YoY movement for Gross Profit: rose 6.19% in 2021, then soared 36.67% in 2022.
  • A 5-year view of Gross Profit shows it stood at $88.0 million in 2021, then skyrocketed by 31.54% to $115.7 million in 2022, then grew by 18.21% to $136.8 million in 2023, then skyrocketed by 30.34% to $178.3 million in 2024, then rose by 15.14% to $205.3 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Gross Profit are $205.3 million (Q4 2025), $196.9 million (Q3 2025), and $180.0 million (Q2 2025).